Gaudium IVF & Women Health came to market through an IPO that opened on 20 February 2026 and closed on 24 February 2026, and the shares listed on 27 February 2026 on BSE, NSE. The price band was ₹75 to ₹79 per share and one lot was 189 shares, so the minimum application was ₹14,931. The issue size was ₹165 crore. It combined a fresh issue of new shares with an offer for sale by existing shareholders.
Bigshare Services Pvt.Ltd was the registrar to the issue, and Sarthi Capital Advisors Pvt.Ltd was the lead manager.
As of 24 February 2026.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization treatments throughout India and have expanded into several states utilizing a hub-and-spoke model. The company has more than thirty locations. These include seven hubs (centres) and twenty-eight spokes.
The strategic alliance between the organization and Infertility Experts, referred to as Spokes, was forged in order to meet the mutual goal of spreading awareness about Assisted Reproductive Technology or ART and In Vitro Fertilization or IVF treatments.The patients come from various countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. The company has hubs in Delhi, two Janakpuri and Kailash Colony; Mumbai; Khar West; Ludhiana; Srinagar; Patna;
and Bangalore, covering all important locations across the subcontinent. This company offers a range of specialized fertility services: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and ovulation induction. Our treatments are specifically directed for a variety of infertility conditions in both males and females. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis and high-risk pregnancy management for women with complex fertility history or health conditions.
These facilities cover a wide scope of male infertility treatments, right from advanced sperm retrieval techniques.
As described in the offer document.
| Metric | 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Gaudium IVF mobilises Rs 49.5 crore through anchor book for Rs 165-crore IPO. Gaudium IVF has allocated 62.65 lakh shares to four anchor investors at the higher price band. Meru Investment Fund was the largest among the anchor investors, investing close to Rs 17 crore for 21.51 lakh shares, followed by Sanshi Fund, which invested 15.8 lakh shares worth Rs 12.5 crore. Hornbill Orchid India Fund, and Carnelian India Multi-Strategy Fund invested 12.6 lakh shares worth Rs 10 crore each.
Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna. Promoter holding 99.99% before the issue and 71.30% after.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Gaudium IVF & Women Health IPO was a ₹165 crore book-built issue, comprising a fresh issue of ₹90 crore and an offer for sale of ₹75 crore. It was priced at ₹75–₹79 per share with a lot size of 189 shares (₹14,931). The IPO was open from February 20 to February 24, 2026 and was subscribed 7.27x. Shares listed on BSE and NSE on February 27, 2026 at ₹83, a 5.1% premium to the issue price of ₹79.
Bigshare Services Pvt. Ltd. is the registrar. Sarthi Capital Advisors Pvt. Ltd. is the book running lead manager.
The price band of Gaudium IVF & Women Health IPO is ₹75 to ₹79 per share.
The lot size of Gaudium IVF & Women Health IPO is 189 shares.
The minimum investment for Gaudium IVF & Women Health IPO is approximately ₹14,931 based on the upper price band.
The allotment date of Gaudium IVF & Women Health IPO is Feb 25, 2026.
Gaudium IVF & Women Health IPO listed on Feb 27, 2026. It was issued at ₹83.0(NSE) and is currently around ₹104.23 as on 2-Nov-2026 3:30 PM, which is approximately 31.9% versus issue price. The 52-week high is ₹163.18.
You can check Gaudium IVF & Women Health IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Gaudium IVF & Women Health IPO allotment status on Rupix for quick and easy access.
₹75 to ₹79 per share, against a face value of ₹5. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 189 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,931.
₹14,931, for one lot of 189 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 20 February 2026 and closed on 24 February 2026.
The basis of allotment was published on 25 February 2026 by Bigshare Services Pvt.Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 27 February 2026 on BSE, NSE.
The issue size was ₹165 crore. The fresh issue was 1,13,92,500 shares (aggregating up to ₹90 crore). The offer for sale was 94,93,700 shares (aggregating up to ₹75 crore).